Gilead Sciences Inc. (GILD) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Gilead Sciences Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Gilead Sciences Inc. (GILD) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $197.3B. It trades at $159.20, up 0.08% today. 22 analysts' average target of $160.05 implies +0.5% from today's price. Kronos AI's 30-day forecast is −14.7% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $160.05 |
| Low – high | $126.00 – $177.00 |
| Analysts | 22 |
| Upside to average | +0.5% |
Kronos AI 30-day forecast
| Expected close | $135.69 (−14.7%) |
| Likely range | −17.7% … −12.9% |
| As of | 2026-10-27 |
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator